Author(s): M. Sharmalkumar, N. Arunagirinathan, D. Anand, K. P. Girivasan, M. Baskar, M. R. Rameshkumar, A. Elumalai, M. Ravi Kumar

Email(s): ravikumar_micro@rediffmail.com

DOI: 10.5958/0974-360X.2020.00664.2   

Address: M. Sharmalkumar1, N. Arunagirinathan2, D. Anand3, K. P. Girivasan1, M. Baskar1, M. R. Rameshkumar4, A. Elumalai1, M. Ravi Kumar1*
1PG and Research Department of Botany, Government Arts College for Men (Autonomous) Nandanam, Affiliated to the University of Madras, Chennai-600035, India.
2 PG and Research Department of Microbiology and Biotechnology, Presidency College (Autonomous), Affiliated to the University of Madras, Chennai 600005, India.
3Department of Plant Biology and Biotechnology R.K.M Vivekananda College, Affiliated to the University of Madras, Chennai – 600004, India.
4Infectious Diseases Laboratory, YRG Centre for AIDS Research and Education, Voluntary Health Services Hospital Campus, Chennai- 600113, Tamil Nadu, India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 8,     Year - 2020


ABSTRACT:
Microorganisms associated with marine sponges represent a rich source of bioactive compounds. In this study, an attempt was made to find out the antimicrobial and anticancer activity of symbiotic bacteria associated with marine sponge. A total of nine bacterial species were isolated from the marine sponge Clathria frondifera and they were screened for their antibacterial activity against clinical pathogens such as Staphylococcus aureus and Escherichia coli using agar overlay method. Among the nine isolates, two unidentified bacterial species GACSB 1 and GACSB 2 exhibited antibacterial activity against the clinical pathogen tested. Of them, GACSB 1 was pigmented bacterium exhibited moderate activity and GACSB 2 was non-pigmented bacterium exhibited significant activity. Of these two bacterial isolates pigment producer was identified as Pseudoalteromonas ruthenica MK568059 (GACSB 1) and non-pigment producer was identified as Pseudoalteromonas sp. MK568069 (GACSB 2) using 16s rRNA gene sequencing method. Furthermore, bacterial crude extract from Pseudoalteromonas sp was tested against multidrug-resistant (MDR) bacterial pathogens and Candida albicans by agar well diffusion method and anti-cancer activity against human ovarian teratocarcinoma cancer PA- 1 cell line. The extract showed moderate activity against MDR Acinetobacter baumannii and Non MDR Candida albicans when compared with other bacteria tested and also it showed moderate anticancer activity against ovarian cancer PA 1 cell line. This study concludes that the Pseudoalteromonas sp. isolated from Clathria frondifera would be a good source of natural bioactive compounds and this will leads to the discovery of new drug for crucial clinical ailments.


Cite this article:
M. Sharmalkumar, N. Arunagirinathan, D. Anand, K. P. Girivasan, M. Baskar, M. R. Rameshkumar, A. Elumalai, M. Ravi Kumar. In-vitro study on Antimicrobial and Anticancer activities of marine sponge Clathria frondifera associated bacteria. Research J. Pharm. and Tech. 2020; 13(8):3753-3758. doi: 10.5958/0974-360X.2020.00664.2

Cite(Electronic):
M. Sharmalkumar, N. Arunagirinathan, D. Anand, K. P. Girivasan, M. Baskar, M. R. Rameshkumar, A. Elumalai, M. Ravi Kumar. In-vitro study on Antimicrobial and Anticancer activities of marine sponge Clathria frondifera associated bacteria. Research J. Pharm. and Tech. 2020; 13(8):3753-3758. doi: 10.5958/0974-360X.2020.00664.2   Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-8-37


REFERENCES:
1.    Boopathy S, Ajith kumar TT,  Kathiresan K. Isolation of symbiotic bacteria and bioactive protein from the marine sponge, Callyspongia diffusa. Indian Journal of Biotechnology. 2009; 8: 272-275.
2.    Brusca RC, Brusca GJ. Phylum Porifera: The sponges, in Invertebrates, edited by AF sinauer (Sinauer Press, Sunderland, Mass) 1990; 181-210.
3.    Kathiresan K, Nabeel A, Manivannan S. Bioprospecting of marine organisms for novel bioactive compounds. J Sci Trans Environ Technol. 2008; 1: 107-120.
4.    Wilkinson CR. Significance of microbial symbionts in sponge evolution and ecology. Symbiosis. 1987; 4: 135-146.
5.    Burgess JG, Jordan EM, Berge M, Mearns-Spragg A, Boyd KG. Microbial antagonism: a neglected avenue of natural products research. J. Biotechnol. 1999; 70: 27-32.
6.    Schupp P, Eder C, Proksch P, Warry VV, Schneider B, Herderich M, Paul VV. Staurosporine derivatives from the ascidi- can Eudistoma toealensis and its predatory flatworm Pseudceros sp. J. Nat. Prod. 1999; 62(7): 959-962.
7.    Proksch P, Edrada RA, Ebel R. Drugs from the seas-current status and microbiological implications. Appl. Microbiol. Biotechnol. 2002; 59: 125-134.
8.    Thakur AN, Thakur NL, Indap NM, Pandit RA, Datar V, Muller WEG. Antiangiogenic, antimicrobial and cytotoxic potential of sponge associated bacteria. Mar Biotechnol. 2005; 7(3): 245-252.
9.    Ramesh Kumar MR, Arunagirinathan N, Srivani S, Dhanasezhian A, Vijaykanth N, Manikandan N, Balakrishnan S, Vignesh R, Balakrishnan P, Solomon S, Solomon SS. Dissemination of trimethoprim–sulfamethoxazole drug resistance genes associated with class 1 and class 2 integrons among gram-negative bacteria from HIV patients in South India. Microbial Drug Resistance. 2017; 23(5): 1-7.
10.    Hassan BAR. Main critical side effects associated with chemotherapy used in cancer treatment. Pharm. Anal. Acta. 2012; 3(5).
11.    National Research Council. From Monsoons to Microbes: Understanding the Ocean's Role in Human Health. Washington, DC: The National Academies Press. 1999.
12.    Thomas PA. Porifera, in Faunal diversity in India, edited by J R B Alfred, A K Das and A K Sanyal (ENVIS Centre Zoological Survey of India, Kolkatta), 1998; 28-36.
13.    Hentschel U, Schmid M, Wagner M, Fieseler L, Gernert C, Hacker J. Isolation and Phylogenetic analysis of bacteria with antimicrobial activities from the Mediterranean sponges Aplysina aerophoba and Aplysina caernicola. FEMS Microbiol Ecol. 2001; 35(3): 305-312.
14.    Collins CH, Lyne PM, Grange JM, Falkinham JO. Collins and Lyne’s Microbiological Methods, 8th ed. London: Edward Arnold; 2004.
15.    Anand TP, Bhat AW, Shouche YS, Roy U, Siddharth J, Sarma SP.  Antimicrobial activity of marine bacteria associated with sponges from the waters off the coast of South East India. Microbiological Research. 2006; 161 (3): 252-262.
16.    Lippert H, Brinkmeyer R, Mulhaupt T, Iken K. Antimicrobial activity in sub-Arctic marine invertebrates Polar Biol. 2003; 26: 591-600.
17.    Sivakumar S, Sharmalkumar M. Isolation, Identification and Molecular characterization of Xylanase producing Streptomyces sp from marine ecosystem. Int J Pharm Bio Sci. 2016; 7(1): 201-206.
18.    Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65: 55-63.
19.    Skariyachan S, Rao AG, Patil M., Saikia B, Bharadwaj KNV, Rao GSJ. Antimicrobial potential of metabolites extracted from bacterial symbionts associated with marine sponges in coastal area of Gulf of Mannar Biosphere, India. Letters in Applied Microbiology. 2013; 58: 231-241.
20.    Manikandan S, Ganesapandian S, Sangeetha N, Kumaragur AK. Antimicrobial activity of marine sponges associated some marine bacterial metabolites against Multi Drug Resistant Human pathogens. Research Journal of Microbiology. 2014; 9(1): 25-33.
21.    Offret C, Desriac F, Le Chevalier P, Mounier J, Jegou C, Fleury Y. Spotlight on Antimicrobial metabolites from the marine bacteria Pseudoalteromonas: Chemodiversity and Ecological Significance. Mar. Drugs. 2016; 14(7): 1-26.
22.    Gauthier G, Gauthier M, Christen R. Phylogenetic analysis of the genera Alteromonas, Shewanella, and Moritella using genes coding for small-subunit rRNA sequences and division of the genus Alteromonas into two genera, Alteromonas (emended) and Pseudoalteromonas gen. nov., and proposal of twelve new species combinations. Int. J. Syst. Bacteriol. 1995; 45: 755-761.
23.    Ivanova E.P, Sawabe T, Lysenko  AM,  Gorshkova NM, Svetashev VI, Nicolau DV, Yumoto N, Taguchi T, Yoshikawa S, Christen R, Mikhailoy VV. Pseudoalteromonas ruthenica sp. nov., isolated from marine invertebrates. Int J Syst Evol Microbiol. 2002a; 52: 235-240.
24.    Ivanova EP, Shevchenko LS, Sawabe T, Lysenko AM, Svetashev VI, Gorshkova NM, Satomi M, Christen R, Mikhailoy VV. Pseudoalteromonas maricaloris sp. nov., isolated from an Australian sponge, and reclassification of [Pseudoalteromonas aurantia] NCIMB 2033 as Pseudoalteromonas flavipulchra sp. nov.International Journal of Systematic and Evolutionary Microbiology. 2002b; 52: 263-271.
25.    Saravanan P, Venkata Nancharaiah Y, Venugopal VP, Subbarao T, Jayachandran S. Biofilm formation by Pseudoalteromonas ruthenica and its removal by chlorine. Biofouling. 2006; 22(6): 371-381.
26.    Holmstrom, C, James S,  Neilan BA,  White DC, Kjelleberg S. Pseudoalteromonas tunicata sp. nov., a bacterium that produces antifouling agents. Int J Syst Bacteriol. 1998; 48: 1205-1212.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available